Doctor profile · Federal record
Dr. William Abramovits, M.D.
Dermatology Physician (CMS: Dermatology) · Dallas, TX
- NPI 1154379188
- Accepts Medicare
- MIPS 89.5 / 100 · 2023
- 54 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5310 Harvest Hill RD, #160
Dallas, TX 752305806
(972) 661-2729
fax (972) 661-0227
Credentials & registration
- NPI registered
- May 2006 — 20 yrs on file
- Profile last updated
- July 8, 2007
- Year of graduation
- 1972 — 54 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Texas #H6757
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1154379188. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
265
Distinct HCPCS
6
Medicare allowed
$18,775
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 80 | 16 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 57 | 39 | $91 | |
17110 |
Destruction of skin growth, 1-14 growths | 38 | 28 | $114 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 35 | 21 | $129 | |
17000 |
Destruction of precancer skin growth, 1 growth | 34 | 26 | $53 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 21 | 21 | $113 |
In context: peer comparison
Among 51 peers in Dallas Dermatology Physician, average services per provider: 218. This provider delivers 1.2× the peer median.Open Payments
Industry payments received
All-time total
$11,452
Transactions
164
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen INC. | 15 | $5,680.99 | |
| Novartis Pharmaceuticals Corporation | 11 | $749.75 | |
| Pfizer INC. | 18 | $744.72 | |
| Genzyme Corporation | 14 | $664.04 | |
| Abbvie INC. | 22 | $623.92 | |
| Lilly USA, LLC | 9 | $487.06 | |
| Janssen Biotech, INC. | 8 | $350.74 | |
| E.R. Squibb & Sons, L.L.C. | 10 | $344.87 | |
| Ucb, INC. | 10 | $282.23 | |
| Arcutis Biotherapeutics, INC. | 26 | $271.34 | |
| Sun Pharmaceutical Industries INC. | 3 | $271.11 | |
| Galderma Laboratories, L.P. | 7 | $248.94 | |
| Kyowa Kirin, INC. | 2 | $145.48 | |
| Regeneron Healthcare Solutions, INC. | 4 | $103.02 | |
| Incyte Corporation | 5 | $95.29 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
37
Patients
0
Total drug cost
$49,197
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Dupixent Pen (Dupilumab) | Brand | 13 | 0 | $48,456 |
| Halobetasol Propionate | Generic | 13 | 0 | $251 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 11 | 0 | $490 |
Frequently asked questions
What is Dr. William Abramovits's medical specialty?
Dr. William Abramovits practices Dermatology Physician in Dallas, TX.
Where does Dr. William Abramovits practice?
Dr. William Abramovits practices at 5310 Harvest Hill RD, Dallas, TX 752305806. Office phone: 9726612729.
What is Dr. William Abramovits's NPI?
Dr. William Abramovits's National Provider Identifier (NPI) is 1154379188, issued by NPPES.
Does Dr. William Abramovits accept Medicare assignment?
Yes. Dr. William Abramovits accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. William Abramovits commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of skin growth, 1-14 growths (HCPCS 17110). Source: CMS Medicare Physician & Other Practitioners file.